» Articles » PMID: 15839907

The Role of Bisphosphonates in the Treatment of Prostate Cancer

Overview
Journal BJU Int
Specialty Urology
Date 2005 Apr 21
PMID 15839907
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation.

Malamas A, Gameiro S, Knudson K, Hodge J Oncotarget. 2016; 7(52):86937-86947.

PMID: 27893426 PMC: 5341329. DOI: 10.18632/oncotarget.13520.


Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid.

Aapro M, Saad F Ther Adv Urol. 2012; 4(2):85-101.

PMID: 22496711 PMC: 3317544. DOI: 10.1177/1756287212441234.


Use of bisphosphonates in prostate cancer: Current status.

Nayyar R, Gupta N Indian J Urol. 2009; 23(1):51-4.

PMID: 19675763 PMC: 2721496. DOI: 10.4103/0970-1591.30267.


Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.

Foster B, Tompkins K, Rutherford R, Zhang H, Chu E, Fong H Birth Defects Res C Embryo Today. 2008; 84(4):281-314.

PMID: 19067423 PMC: 4526155. DOI: 10.1002/bdrc.20136.


Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.

Tuomela J, Valta M, Vaananen K, Harkonen P BMC Cancer. 2008; 8:81.

PMID: 18371232 PMC: 2294135. DOI: 10.1186/1471-2407-8-81.